Teleflex, Inc. (TFX)
136.29
-0.29
(-0.21%)
USD |
NYSE |
Oct 23, 16:00
136.32
+0.03
(+0.02%)
Pre-Market: 20:00
Teleflex Enterprise Value : 8.333B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 8.333B |
| October 22, 2026 | 8.345B |
| October 21, 2026 | 8.083B |
| October 20, 2026 | 8.115B |
| October 19, 2026 | 8.052B |
| October 16, 2026 | 8.084B |
| October 15, 2026 | 7.991B |
| October 14, 2026 | 7.782B |
| October 13, 2026 | 7.830B |
| October 12, 2026 | 7.884B |
| October 09, 2026 | 7.859B |
| October 08, 2026 | 7.820B |
| October 07, 2026 | 7.832B |
| October 06, 2026 | 7.843B |
| October 05, 2026 | 7.864B |
| October 02, 2026 | 7.817B |
| October 01, 2026 | 7.901B |
| September 30, 2026 | 7.856B |
| September 29, 2026 | 7.910B |
| September 28, 2026 | 7.955B |
| September 25, 2026 | 7.730B |
| September 24, 2026 | 7.646B |
| September 23, 2026 | 7.716B |
| September 22, 2026 | 7.850B |
| September 21, 2026 | 7.846B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.834B |
| September 17, 2026 | 7.879B |
| September 16, 2026 | 7.981B |
| September 15, 2026 | 8.025B |
| September 14, 2026 | 8.079B |
| September 11, 2026 | 8.108B |
| September 10, 2026 | 8.151B |
| September 09, 2026 | 8.308B |
| September 08, 2026 | 8.363B |
| September 04, 2026 | 8.420B |
| September 03, 2026 | 8.488B |
| September 02, 2026 | 8.531B |
| September 01, 2026 | 8.510B |
| August 31, 2026 | 8.577B |
| August 28, 2026 | 8.476B |
| August 27, 2026 | 8.393B |
| August 26, 2026 | 8.436B |
| August 25, 2026 | 8.497B |
| August 24, 2026 | 8.418B |
| August 21, 2026 | 8.440B |
| August 20, 2026 | 8.276B |
| August 19, 2026 | 8.314B |
| August 18, 2026 | 8.147B |
| August 17, 2026 | 8.196B |
| August 14, 2026 | 8.370B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 10.45B |
| Penumbra, Inc. | 12.33B |
| Abbott Laboratories | 207.10B |
| Becton, Dickinson & Co. | 70.12B |
| Boston Scientific Corp. | 78.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 41.76M |
| Revenue (Quarterly) | 570.33M |
| Total Expenses (Quarterly) | 528.57M |
| EPS Diluted (Quarterly) | 2.283 |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 7.32% |
| Earnings Yield | -17.09% |
| Operating Earnings Yield | 4.77% |
| Normalized Earnings Yield | -10.33 |